CNO Global Funding

Overview

Deal Type Debt Capital Markets
Size $400 Million
FA-Backed Notes due 2025
$500 Million
FA-Backed Notes due 2029
Client & Transactional Partners CNO Global Funding
Our Role Active Bookrunner

Summary

On January 3, 2022, KeyBanc Capital Markets acted as Active Bookrunner on CNO Global Funding’s (the “Company”) $900 Million FA-Backed Notes due 2025 & 2029 (the “Notes”) offering. The Notes priced at respective coupons of 1.650% and 2.650%. Interest on the two Notes are payable on January 6 and July 6, beginning July 6, 2022. The Notes will mature on January 6, 2025 and January 6, 2029. The Company plans to use proceeds from the offering to purchase one or more Funding Agreements from Bankers Life and Casualty Company.

CNO Global Funding is a special purpose statutory trust created on August 18, 2021 for the purpose of, among other things, issuing FA Backed Notes. The purpose of the Company is to: (i) enter into certain agreements in connection with the FABN Program; (ii) issue and sell FA Backed Notes; and (iii) use the net proceeds from the sale of FA-Backed Notes to purchase one or more funding agreements from Bankers Life and Casualty Company.

CNO Financial Group, a Delaware corporation, is a holding company for a group of insurance companies operating throughout the United States that develop, market and administer health insurance, annuity, individual life insurance and other insurance products. CNO Financial focuses on serving middle-income pre-retiree and retired Americans, which it believes are attractive, underserved, high growth markets.

Recent Deals

July 2025

a portfolio company of 

and

$1.815 Billion

Senior Secured Credit Facilities

$900 Million

8.50% First Lien Secured Notes due 2032

Joint Lead Arranger
Joint Bookrunner

radiology-partners
June 2025

 

El Camino Commons

$74.8 Million

Construction Loan & LIHTC Equity

el-camino-commons
June 2025

Hill Estates

Hill Estates

$67.5 Million

Bridge to Perm Loan, Acquisition

hill-estates
June 2025

thermogenics

a portfolio company of

audax

acquired by

morgan stanley

Sell-Side Advisor

thermogenics

Connect With Us

Find an Expert